{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:22:32Z","timestamp":1776867752392,"version":"3.51.2"},"reference-count":58,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.expneurol.2013.05.014","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:44:29Z","timestamp":1369788269000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets"],"prefix":"10.1016","volume":"256","author":[{"given":"Chenere P.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mal\u00fa G.","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.05.014_bb0005","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1046\/j.1460-9568.2000.00110.x","article-title":"Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions","volume":"12","author":"Bernardo","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0010","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/cdd.2009.217","article-title":"Paraquat and Parkinson's disease","volume":"17","author":"Berry","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0020","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/jnr.23061","article-title":"Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model","volume":"90","author":"Choi","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0025","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/20024091064282","article-title":"A critical review of the toxicological effects of carrageenan and processed eucheuma seaweed on the gastrointestinal tract","volume":"32","author":"Cohen","year":"2002","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1755-5949.2012.00372.x","article-title":"Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia","volume":"18","author":"Cui","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000328989","article-title":"The yin and yang of microglia","volume":"33","author":"Czeh","year":"2011","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcb.22860","article-title":"Differential regulation by fucoidan of IFN-gamma-induced NO production in glial cells and macrophages","volume":"111","author":"Do","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.me.27.020176.001015","article-title":"Biology of endotoxin","volume":"27","author":"Elin","year":"1976","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vph.2006.05.002","article-title":"Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists","volume":"45","author":"Erbe","year":"2006","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0143-4179(85)90053-8","article-title":"Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing","volume":"5","author":"Fallon","year":"1985","journal-title":"Neuropeptides"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1742-2094-9-38","article-title":"Involvement of PPAR-gamma in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease","volume":"9","author":"Garrido-Gil","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0070","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","article-title":"Role of microglia in CNS inflammation","volume":"585","author":"Graeber","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuro.2012.01.018","article-title":"Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system","volume":"33","author":"Hernandez-Romero","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/WCO.0b013e32832a3225","article-title":"Role of microglial redox balance in modulation of neuroinflammation","volume":"22","author":"Innamorato","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2012.01.022","article-title":"Lipopolysaccharide-induced nigral inflammation leads to increased IL-1beta tissue content and expression of astrocytic glial cell line-derived neurotrophic factor","volume":"510","author":"Iravani","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","article-title":"Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms","volume":"1471","author":"Kumar","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/frne.1997.0155","article-title":"Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review","volume":"18","author":"Lenkei","year":"1997","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-6-49","article-title":"A Wnt1 regulated Frizzled-1\/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection","volume":"6","author":"L'Episcopo","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0110","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1523\/JNEUROSCI.5259-11.2012","volume":"32","author":"L'Episcopo","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0120","first-page":"1133","article-title":"Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage","volume":"298","author":"Liu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2011.09.033","article-title":"Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease","volume":"226","author":"Luchtman","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/syn.21543","article-title":"Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease","volume":"66","author":"Maia","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11481-012-9363-2","article-title":"Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"7","author":"Ojha","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2005.7.685","article-title":"Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease","volume":"7","author":"Przedborski","year":"2005","journal-title":"Antioxid. Redox Signal."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2013.05.014_bb0155","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1067\/mai.2001.116862","article-title":"Endotoxin-stimulated innate immunity: a contributing factor for asthma","volume":"108","author":"Reed","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cne.20664","article-title":"Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain","volume":"490","author":"Rigby","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2012.03.010","article-title":"Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression","volume":"246","author":"Sadeghian","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0180","series-title":"Parkinson's Disease and Movement Disorders","first-page":"78","article-title":"Major symptoms and signs of Parkinson's disease","author":"Sanchetee","year":"2008"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0959-4388(95)80060-3","article-title":"Silencing is golden: negative regulation in the control of neuronal gene transcription","volume":"5","author":"Schoenherr","year":"1995","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharmthera.2009.05.006","article-title":"30years of dynorphins\u2014new insights on their functions in neuropsychiatric diseases","volume":"123","author":"Schwarzer","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0205","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.freeradbiomed.2012.02.005","article-title":"Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse","volume":"52","author":"Srivastava","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0210","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1523\/JNEUROSCI.21-03-00798.2001","article-title":"Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium","volume":"21","author":"Stumm","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0215","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0220","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","article-title":"The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders","volume":"69","author":"Tejeda","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0225","doi-asserted-by":"crossref","first-page":"e34138","DOI":"10.1371\/journal.pone.0034138","article-title":"Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease","volume":"7","author":"Thornton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1289\/ehp.01109983","article-title":"Review of harmful gastrointestinal effects of carrageenan in animal experiments","volume":"109","author":"Tobacman","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ecam\/nel008","article-title":"Comparison of anti-inflammatory activities of six curcuma rhizomes: a possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract","volume":"3","author":"Tohda","year":"2006","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0240","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neurobiolaging.2010.08.006","article-title":"Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration","volume":"33","author":"Villar-Cheda","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0245","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2353\/ajpath.2010.091109","article-title":"Neurokinin-1 receptor (NK1-R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNS","volume":"177","author":"Vinet-Oliphant","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1742-2094-9-124","article-title":"Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice","volume":"9","author":"Wang","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.3875898","article-title":"Distinct monoamine oxidase A and B populations in primate brain","volume":"230","author":"Westlund","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0260","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-4522(88)90250-3","article-title":"Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem","volume":"25","author":"Westlund","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin\u2013angiotensin\u2014a new look at an old system","volume":"95","author":"Wright","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0270","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1007\/s11064-008-9675-z","article-title":"Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron\/glia culture","volume":"33","author":"Yang","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0275","first-page":"1307","article-title":"Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides","volume":"290","author":"You","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0280","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.neurobiolaging.2012.06.002","article-title":"NRSF\/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP","volume":"34","author":"Yu","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2013.05.014_bb0285","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1755-5949.2012.00347.x","article-title":"Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide","volume":"18","author":"Yuan","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2013.05.014_bb0290","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jnc.12010","article-title":"A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats","volume":"123","author":"Zhou","year":"2012","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861300160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861300160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T01:44:13Z","timestamp":1645580653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861300160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":58,"alternative-id":["S001448861300160X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.05.014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}